Concepedia

Author

Christa Krupski

Cincinnati Children's Hospital Medical Center

Also Known As

C. Krupski, Christa Krupski, Manisha Madkaikar

40

Publications

842

Citations

14

H-Index

37

Concepts

All Affiliations

Cincinnati Children's Hospital Medical CenterHarvard UniversityEmory UniversityChildren's Healthcare of AtlantaChildren's Hospital Colorado
CK

About

Christa Krupski is an author at Cincinnati Children's Hospital Medical Center specializing in medicine, cell transplantation, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

432

2

Cellular Therapies

4

4

190

3

Health Sciences

3

3

147

4

Blood Transplantation

2

2

39

5

Clinical Immunology

1

1

12

Christa Krupski

×

13

Publications

693

Citations

12

H-Index

YearCitations

Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2)

Pui Y. Lee, Erinn S. Kellner, Yuelong Huang,

Journal of Allergy and Clinical Immunology

2020

143

Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

Vanessa A. Fabrizio, Jaap Jan Boelens, Audrey Mauguen,

Blood Advances

2021

103

Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report

Vanessa A. Fabrizio, Christine L. Phillips, Adam Lane,

Blood Advances

2021

74

Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia

Liora M. Schultz, Anne Eaton, Christina Baggott,

Journal of Clinical Oncology

2022

71

Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia

Amy Moskop, Lauren Pommert, Christina Baggott,

Blood Advances

2022

61

Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors

Shernan G. Holtan, Nandita Khera, John E. Levine,

Blood

2016

58

Chimeric Antigen Receptor T Cell Therapy in Patients with Multiply Relapsed or Refractory Extramedullary Leukemia

Jeremy D. Rubinstein, Christa Krupski, Adam Nelson,

Biology of Blood and Marrow Transplantation

2020

49

Disease Burden Impacts Outcomes in Pediatric and Young Adult B-Cell Acute Lymphoblastic Leukemia after Commercial Tisagenlecleucel: Results from the Pediatric Real World CAR Consortium (PRWCC)

Liora M. Schultz, Christina Baggott, Snehit Prabhu,

Blood

2020

38

Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation

Sharat Chandra, Shanmuganathan Chandrakasan, Blachy J. Dávila Saldaña,

Journal of Clinical Immunology

2020

25

High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy

Lynn Lee, Christa Krupski, Jason Clark,

Blood Advances

2020

24

Page 1